A bipartisan group of lawmakers has sent a letter to the Department of Health and Human Services, asking the agency to cancel ...

A bipartisan group of 163 lawmakers is urging the Department of Health and Human Services (HHS) to cancel an upcoming pilot ...

The hospital lobby wants the Trump administration to investigate Johnson & Johnson, Eli Lilly, Sanofi, Novartis and Bristol ...

The nonpartisan scorekeeper’s new report reinforces longstanding concerns about the 340B drug discount program, including ...

More than 160 lawmakers have urged the Trump administration to abandon a newly announced pilot program that would allow ...

Spending through the 340B Drug Pricing Program rose by 565% between 2010 and 2021, increasing from $6.6 billion to $43.9 billion, according to a report from the Congressional Budget Office. In 2021, ...

The AHA Sept. 8 urged the Federal Trade Commission and Antitrust Division of the Department of Justice to investigate several ...

On August 6, 2025, the U.S. Court of Appeals for the Second Circuit issued an opinion allowing a case challenging drug ...

Novo Nordisk plans to trim 9,000 jobs — roughly 11% of its workforce — as it seeks to remake itself for a more competitive ...

A group of House lawmakers is urging HHS to scrap or revise its proposed 340B rebate model pilot program, warning the model could dismantle the original intent of the program and harm safety-net ...

The pharmaceutical lobby is ramping up its opposition to nonprofit health systems’ expanding use of the 340B Drug Discount ...

The 100% woman-owned consulting firm partners with healthcare organizations to help them understand, implement, and optimize ...